vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $32.0M, roughly 1.2× Silvercrest Asset Management Group Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -3.7%, a 3.3% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-5.8M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs 2.7%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
GYRE vs SAMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $32.0M |
| Net Profit | $-1.4M | $-120.0K |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | -2.8% |
| Net Margin | -3.7% | -0.4% |
| Revenue YoY | 33.4% | -0.0% |
| Net Profit YoY | -340.1% | -107.4% |
| EPS (diluted) | $-0.01 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | $32.0M | ||
| Q3 25 | $30.6M | $31.3M | ||
| Q2 25 | $26.8M | $30.7M | ||
| Q1 25 | $22.1M | $31.4M | ||
| Q4 24 | $27.9M | $32.0M | ||
| Q3 24 | $25.5M | $30.4M | ||
| Q2 24 | $25.2M | $31.0M | ||
| Q1 24 | $27.2M | $30.3M |
| Q4 25 | $-1.4M | $-120.0K | ||
| Q3 25 | $5.9M | $618.0K | ||
| Q2 25 | $1.6M | $1.9M | ||
| Q1 25 | $3.7M | $2.5M | ||
| Q4 24 | $569.0K | $1.6M | ||
| Q3 24 | $2.9M | $2.3M | ||
| Q2 24 | $4.5M | $2.7M | ||
| Q1 24 | $9.9M | $3.0M |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | -2.8% | ||
| Q3 25 | 22.7% | 4.3% | ||
| Q2 25 | 8.1% | 13.2% | ||
| Q1 25 | 10.3% | 15.4% | ||
| Q4 24 | 2.4% | 6.1% | ||
| Q3 24 | 16.6% | 14.6% | ||
| Q2 24 | 12.7% | 17.1% | ||
| Q1 24 | 29.7% | 19.5% |
| Q4 25 | -3.7% | -0.4% | ||
| Q3 25 | 19.4% | 2.0% | ||
| Q2 25 | 5.9% | 6.3% | ||
| Q1 25 | 16.9% | 7.9% | ||
| Q4 24 | 2.0% | 5.1% | ||
| Q3 24 | 11.2% | 7.4% | ||
| Q2 24 | 18.0% | 8.6% | ||
| Q1 24 | 36.6% | 9.9% |
| Q4 25 | $-0.01 | $0.02 | ||
| Q3 25 | $0.03 | $0.07 | ||
| Q2 25 | $0.00 | $0.21 | ||
| Q1 25 | $0.00 | $0.26 | ||
| Q4 24 | $0.00 | $0.16 | ||
| Q3 24 | $0.01 | $0.24 | ||
| Q2 24 | $0.01 | $0.28 | ||
| Q1 24 | $0.03 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.0M | $50.3M |
| Total Assets | $166.1M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $44.1M | ||
| Q3 25 | $60.0M | $36.1M | ||
| Q2 25 | $54.4M | $30.0M | ||
| Q1 25 | $29.9M | $36.3M | ||
| Q4 24 | $26.7M | $68.6M | ||
| Q3 24 | $25.1M | $58.1M | ||
| Q2 24 | $25.1M | $49.9M | ||
| Q1 24 | $37.4M | $39.7M |
| Q4 25 | $106.0M | $50.3M | ||
| Q3 25 | $101.9M | $58.9M | ||
| Q2 25 | $92.0M | $64.6M | ||
| Q1 25 | $68.1M | $80.0M | ||
| Q4 24 | $63.3M | $80.7M | ||
| Q3 24 | $63.2M | $84.6M | ||
| Q2 24 | $60.4M | $85.3M | ||
| Q1 24 | $56.6M | $83.9M |
| Q4 25 | $166.1M | $166.6M | ||
| Q3 25 | $159.4M | $157.6M | ||
| Q2 25 | $152.6M | $152.7M | ||
| Q1 25 | $129.8M | $159.9M | ||
| Q4 24 | $125.4M | $194.4M | ||
| Q3 24 | $125.2M | $184.2M | ||
| Q2 24 | $120.9M | $177.6M | ||
| Q1 24 | $122.0M | $170.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $18.6M |
| Free Cash FlowOCF − Capex | $-5.8M | $15.0M |
| FCF MarginFCF / Revenue | -15.5% | 46.9% |
| Capex IntensityCapex / Revenue | 0.4% | 11.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | $18.6M | ||
| Q3 25 | $4.7M | $14.6M | ||
| Q2 25 | $2.1M | $13.8M | ||
| Q1 25 | $-129.0K | $-24.7M | ||
| Q4 24 | $-2.8M | $21.6M | ||
| Q3 24 | $1.7M | $13.3M | ||
| Q2 24 | $-5.5M | $16.0M | ||
| Q1 24 | $2.9M | $-24.1M |
| Q4 25 | $-5.8M | $15.0M | ||
| Q3 25 | $4.0M | $13.8M | ||
| Q2 25 | $1.8M | $13.4M | ||
| Q1 25 | $-251.0K | $-25.1M | ||
| Q4 24 | $-2.8M | $19.9M | ||
| Q3 24 | $1.0M | $12.9M | ||
| Q2 24 | $-6.9M | $15.6M | ||
| Q1 24 | $2.7M | $-24.7M |
| Q4 25 | -15.5% | 46.9% | ||
| Q3 25 | 13.1% | 44.1% | ||
| Q2 25 | 6.8% | 43.6% | ||
| Q1 25 | -1.1% | -80.0% | ||
| Q4 24 | -10.1% | 62.2% | ||
| Q3 24 | 4.1% | 42.4% | ||
| Q2 24 | -27.5% | 50.4% | ||
| Q1 24 | 9.8% | -81.6% |
| Q4 25 | 0.4% | 11.4% | ||
| Q3 25 | 2.2% | 2.6% | ||
| Q2 25 | 1.0% | 1.5% | ||
| Q1 25 | 0.6% | 1.3% | ||
| Q4 24 | 0.2% | 5.3% | ||
| Q3 24 | 2.7% | 1.2% | ||
| Q2 24 | 5.8% | 1.1% | ||
| Q1 24 | 0.9% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | 0.79× | 23.62× | ||
| Q2 25 | 1.32× | 7.22× | ||
| Q1 25 | -0.03× | -10.01× | ||
| Q4 24 | -4.85× | 13.34× | ||
| Q3 24 | 0.60× | 5.90× | ||
| Q2 24 | -1.21× | 6.00× | ||
| Q1 24 | 0.29× | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GYRE
Segment breakdown not available.
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
